Biologic Specimen Collection for Sickle Cell Trait
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to learn more about individuals with Sickle Cell Trait (SCT), a condition where a person carries one sickle cell gene but typically does not exhibit symptoms like those of Sickle Cell Disease. Researchers seek to understand how SCT affects blood and whether it might lead to any health issues over time. The trial seeks adults who know or suspect they have SCT and are willing to confirm their status through testing. Participants will help build a clearer picture of what living with SCT means for their health.
As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and enhance understanding of SCT's long-term health impacts.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Why are researchers excited about this trial?
Researchers are excited about the AUNT trial because it aims to deepen our understanding of sickle cell trait, which isn't typically the focus of current treatments. Unlike sickle cell disease, which has established treatment protocols like hydroxyurea and blood transfusions, sickle cell trait often goes unstudied. This trial is unique because it seeks to explore the natural history of the trait, potentially uncovering information that could lead to new insights or interventions. By learning more about how sickle cell trait affects individuals over time, researchers hope to improve health outcomes and provide better guidance for those with the trait.
Who Is on the Research Team?
Julie Kanter, MD
Principal Investigator
National Alliance for Sickle Cell Centers
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Longitudinal Cohort Study
Participants are observed to understand the hematologic phenotype and assess clinical complications of Sickle Cell Trait
Follow-up
Participants are monitored for safety and effectiveness after the main observation period
What Are the Treatments Tested in This Trial?
Interventions
- Biologic Specimen Collection
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Alliance for Sickle Cell Centers
Lead Sponsor
Beam Therapeutics Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.